Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
40 studies found for:    Open Studies | "Hyperthyroidism"
Show Display Options
Rank Status Study
21 Recruiting Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
Conditions: Graves Disease;   Graves Ophthalmopathy;   Graves' Ophthalmopathy Worsened
Interventions: Drug: Antithyroid Drug;   Procedure: Total thyroidectomy
22 Not yet recruiting HIFU vs RAI in the Relapsed Graves' Disease
Condition: Graves Disease
Intervention: Device: Echopulse
23 Recruiting Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Conditions: Thyrotoxicosis;   Graves Disease;   Thyroiditis
Intervention:
24 Recruiting ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy
Condition: Graves Disease
Intervention: Biological: ATX-GD-59
25 Recruiting K1-70 - A Study in Subjects With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: K1-70 intramuscular
26 Recruiting Celecoxib for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Celecoxib;   Drug: artificial tears
27 Recruiting Graves' Orbitopathy and Hypercholesterolemia
Conditions: Graves' Ophthalmopathy;   Hypercholesterolemia
Intervention: Other: No intervention
28 Recruiting The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
Condition: Mild Graves' Ophthalmopathy
Interventions: Drug: Metformin;   Drug: Placebo
29 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Methylprednisolone + ASTED;   Drug: Methylprednisolone +Placebo
30 Recruiting mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)
Condition: Dysthyroid Ophthalmopathies
Intervention:
31 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
Condition: Thyroid Eye Disease
Interventions: Drug: ASTED;   Dietary Supplement: Selenium;   Other: Placebo
32 Recruiting D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
Condition: Graves' Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
33 Recruiting Rituximab (RTX) Therapy in Patients With Active TAO
Condition: Ophthalmopathy, Thyroid-Associated
Interventions: Drug: Rituximab;   Drug: Iv Methylprednisolone;   Drug: peroral methylprednisolone and Methotrexate
34 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
35 Recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Intervention:
36 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
37 Recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%
38 Recruiting Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Hyaluronic Acid Gel injection;   Drug: Saline injection
39 Recruiting Bupivacaine Injection of Eye Muscles to Treat Strabismus
Conditions: Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
Intervention: Drug: Bupivacaine
40 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Study has passed its completion date and status has not been verified in more than two years.